Deferasirox drives ROS-mediated differentiation and induces interferon-stimulated gene expression in human healthy haematopoietic stem/progenitor cells and in leukemia cells
Abstract Background Administration of the iron chelator deferasirox (DFX) in transfusion-dependent patients occasionally results in haematopoiesis recovery by a mechanism remaining elusive. This study aimed to investigate at a molecular level a general mechanism underlying DFX beneficial effects on...
Main Authors: | Tiziana Tataranni, Carmela Mazzoccoli, Francesca Agriesti, Luciana De Luca, Ilaria Laurenzana, Vittorio Simeon, Vitalba Ruggieri, Consiglia Pacelli, Gerardo Della Sala, Pellegrino Musto, Nazzareno Capitanio, Claudia Piccoli |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1293-y |
Similar Items
-
Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
by: Tiziana Tataranni, et al.
Published: (2019-05-01) -
DFM (Design for Manufacturability) metodo taikymas gaminiams iš plastiko gaminti
by: Tamošauskas, Aurimas
Published: (2008) -
PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View
by: Francesca Agriesti, et al.
Published: (2012-01-01) -
Successful Deferasirox Rechallenge and Treating Through Reaction in a Patient with Challenge-Proven Mild Immediate Reaction: A Case Report
by: Sompornrattanaphan M, et al.
Published: (2020-10-01) -
DFX metodo efektyvumo tyrimas konstravimo procese
by: Vasiliauskienė, Eugenija
Published: (2004)